| Paige Woods, | |
|
1233 N 30th St, Billings, MT 59101-0127 | |
| (406) 237-4116 | |
| (406) 237-4125 |
| Full Name | Paige Woods |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 1233 N 30th St, Billings, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962063263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2019022795 (Missouri) | Secondary |
| 207P00000X | Emergency Medicine | MED-PHYS-LIC-112495 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Healthcare | Billings, MT | Hospital |
| Holy Rosary Healthcare | Miles city, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group - Billings Llc | 9638491574 | 219 |
News Archive
A team of scientists from China and the USA has recently described the antiviral efficacy of a monoclonal antibody candidate targeting the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Importantly, they have observed that emerging spike mutations could not affect the potency of this antibody. The study is currently available on the bioRxiv* preprint server.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Union has finalized a EUR 3.3 million grant to the AIPGENE consortium, of which AMT is a member, for the development of a gene therapy product for Acute Intermittent Porphyria.
Obesity and subsequent complications are increasing in frequency worldwide. The accumulation of adipose tissue is associated with increased inflammation, and it has been proposed that modification of proinflammatory responses could alter adipose tissue composition.
Eclipsys Corporation®, The Outcomes Company®, today announced that pediatric hospitals are emerging as a key client base for its Sunrise EPSi™ integrated suite of business performance management solutions. In face of declining reimbursements, both acute and specialty care organizations are seeking the decision support solution as an effective means to become more efficient and improve productivity without sacrificing quality.
Immune cells known as natural killer (NK) cells are linked with pregnancy problems including pre-eclampsia and recurrent miscarriage. Collaborative research between scientists at the Babraham Institute and Centre for Trophoblast Research in Cambridge is illuminating the role that pregnancy-related NK cells play in moderating the biochemical interactions at the boundary between maternal tissues and the developing foetus.
› Verified 4 days ago
| Entity Name | Scl Health Medical Group - Billings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508289703 PECOS PAC ID: 9638491574 Enrollment ID: O20141204001495 |
News Archive
A team of scientists from China and the USA has recently described the antiviral efficacy of a monoclonal antibody candidate targeting the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Importantly, they have observed that emerging spike mutations could not affect the potency of this antibody. The study is currently available on the bioRxiv* preprint server.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Union has finalized a EUR 3.3 million grant to the AIPGENE consortium, of which AMT is a member, for the development of a gene therapy product for Acute Intermittent Porphyria.
Obesity and subsequent complications are increasing in frequency worldwide. The accumulation of adipose tissue is associated with increased inflammation, and it has been proposed that modification of proinflammatory responses could alter adipose tissue composition.
Eclipsys Corporation®, The Outcomes Company®, today announced that pediatric hospitals are emerging as a key client base for its Sunrise EPSi™ integrated suite of business performance management solutions. In face of declining reimbursements, both acute and specialty care organizations are seeking the decision support solution as an effective means to become more efficient and improve productivity without sacrificing quality.
Immune cells known as natural killer (NK) cells are linked with pregnancy problems including pre-eclampsia and recurrent miscarriage. Collaborative research between scientists at the Babraham Institute and Centre for Trophoblast Research in Cambridge is illuminating the role that pregnancy-related NK cells play in moderating the biochemical interactions at the boundary between maternal tissues and the developing foetus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paige Woods, 1233 N 30th St, Billings, MT 59101-0127 Ph: (406) 237-4116 | Paige Woods, 1233 N 30th St, Billings, MT 59101-0127 Ph: (406) 237-4116 |
News Archive
A team of scientists from China and the USA has recently described the antiviral efficacy of a monoclonal antibody candidate targeting the spike receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Importantly, they have observed that emerging spike mutations could not affect the potency of this antibody. The study is currently available on the bioRxiv* preprint server.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Union has finalized a EUR 3.3 million grant to the AIPGENE consortium, of which AMT is a member, for the development of a gene therapy product for Acute Intermittent Porphyria.
Obesity and subsequent complications are increasing in frequency worldwide. The accumulation of adipose tissue is associated with increased inflammation, and it has been proposed that modification of proinflammatory responses could alter adipose tissue composition.
Eclipsys Corporation®, The Outcomes Company®, today announced that pediatric hospitals are emerging as a key client base for its Sunrise EPSi™ integrated suite of business performance management solutions. In face of declining reimbursements, both acute and specialty care organizations are seeking the decision support solution as an effective means to become more efficient and improve productivity without sacrificing quality.
Immune cells known as natural killer (NK) cells are linked with pregnancy problems including pre-eclampsia and recurrent miscarriage. Collaborative research between scientists at the Babraham Institute and Centre for Trophoblast Research in Cambridge is illuminating the role that pregnancy-related NK cells play in moderating the biochemical interactions at the boundary between maternal tissues and the developing foetus.
› Verified 4 days ago
Dr. Mark David Schaefer, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 | |
Richard Lammers, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Deniz Tek, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Jedediah Owen Walker, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
James Evan Buchan, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Samuel Leon Paczkowski, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 | |
Douglas Parker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-4116 Fax: 406-237-4125 |